Dosage and administration
Shake well. Apply once or twice daily. Allow to dry before releasing dog. Use alcohol to remove stains from hands.
Pad Kote
- Manufacturer
- Happy Jack Inc | SV Labs Prescott Corporation | Sigma-Aldrich Manufacturing LLC
- Effective date
- 2024-02-21
- Label type
- OTC ANIMAL DRUG LABEL
- Version
- 5
- Source
- full-release
- Hydrated at
- 2026-06-01 02:42:51
Label at a glance#
ProductPad Kote
Active ingredientcod liver oil, gentian violet, brilliant green
Label structure6 sections
Contacts and useful links#
Websitewww.happyjackinc.com
www.happyjackinc.com
www.happyjackinc.comLabel contents#
Full prescribing information#
DESCRIPTION SECTION
Pad Kote™ was formulated to treat the raw, tender & cracked pads of hunting dogs. Also a terrific healing aid for all types of wounds, including fungal & bacterial infections of the feet, ears & elsewhere. Try Pad Kote™ on cuts, abrasions, sores, burns, tender ears & hot spots (moist dermatitis). Promotes skin cell granulation & epithelial growth.
DIRECTIONS FOR USE
Shake well. Apply once or twice daily. Allow to dry before releasing dog. Use alcohol to remove stains from hands.
CAUTION
Not for use on animals intended for food.
CONTAINS
Active Ingredients
Cod Liver Oil, Gentian Violet, Brilliant Green.
Other Ingredients
Isopropyl Alcohol, Balsam Peru, Glycerine, Cade Oil, Tannic Acid, Turpentine.
SPL UNCLASSIFIED SECTION
SOLD BY:
Happy Jack, Inc.
POB 475
2122 Hwy. 258 S.
Snow Hill, NC 28580
1-252-747-2911
Made in the U.S.A.
Product No. 1054. Rev. 1212
PRINCIPAL DISPLAY PANEL - 58 mL Bottle Label
Since 1946
Happy Jack®
PAD KOTE™
Ask for
Happy Jack®...
Your Dog
Would!
Aids Healing & Toughening of Raw,
Tender & Cracked Pads.
Also Promotes Healing of Fungal
& Bacterial Infections.
2 FL. OZ
(58mL)
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1372937 | brilliant green 1 % / cod liver oil 8.4 % / gentian violet 6.5 % Topical Lotion | PSN | 5 |
| 1372939 | PAD KOTE 8.4 % / 6.5 % / 1 % Topical Lotion | PSN | 5 |
| 1372939 | brilliant green 10 MG/ML / cod liver oil 84 MG/ML / gentian violet 65 MG/ML Topical Lotion [Pad Kote] | SBD | 5 |
| 1372937 | brilliant green 10 MG/ML / cod liver oil 84 MG/ML / gentian violet 65 MG/ML Topical Lotion | SCD | 5 |
| 1372937 | brilliant green 1 % / cod liver oil 8.4 % / gentian violet 6.5 % Topical Lotion | SY | 5 |
| 1372939 | Pad Kote (brilliant green 1 % / cod liver oil 8.4 % / gentian violet 6.5 % ) Topical Lotion | SY | 5 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 23851-054-02 | Pad Kote | 58 mL in 1 BOTTLE, PLASTIC | SUSPENSION | 58 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| brilliant green | ACTIVE INGREDIENT | G0L543D370 | 1 | |
| cod liver oil | ACTIVE INGREDIENT | BBL281NWFG | 1 | |
| gentian violet | ACTIVE INGREDIENT | J4Z741D6O5 | 1 | |
| brilliant green cation | ACTIVE MOIETY | S85JD8CLBH | 1 | |
| cod liver oil | ACTIVE MOIETY | BBL281NWFG | 1 | |
| gentian violet cation | ACTIVE MOIETY | 3GVJ31T6YY | 1 | |
| balsam peru | INACTIVE INGREDIENT | 8P5F881OCY | 1 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| isopropyl alcohol | INACTIVE INGREDIENT | ND2M416302 | 1 | |
| juniper tar | INACTIVE INGREDIENT | 1Q84T0P2G3 | 1 | |
| tannic acid | INACTIVE INGREDIENT | 28F9E0DJY6 | 1 | |
| turpentine | INACTIVE INGREDIENT | XJ6RUH0O4G | 1 |
Products#
Every source-derived product name is available through these pages.
- Pad Kote
- cod liver oil, gentian violet, and brilliant green
- cod liver oil
- gentian violet
- gentian violet cation
- brilliant green
- brilliant green cation
- isopropyl alcohol
- balsam peru
- glycerin
- juniper tar
- tannic acid
- turpentine
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 23851-054 | 23851-054-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| cod liver oil | BBL281NWFG | ACTIB |
| gentian violet | J4Z741D6O5 | ACTIB |
| brilliant green | G0L543D370 | ACTIB |
| isopropyl alcohol | ND2M416302 | IACT |
| balsam peru | 8P5F881OCY | IACT |
| glycerin | PDC6A3C0OX | IACT |
| juniper tar | 1Q84T0P2G3 | IACT |
| tannic acid | 28F9E0DJY6 | IACT |
| turpentine | XJ6RUH0O4G | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| isopropyl alcohol | ISOPROPYL ALCOHOL | ND2M416302 | GEL, METERED / TOPICAL | 525 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| isopropyl alcohol | ISOPROPYL ALCOHOL | ND2M416302 | SOLUTION / TOPICAL | 40 %w/v | ||
| isopropyl alcohol | ISOPROPYL ALCOHOL | ND2M416302 | LOTION, AUGMENTED / TOPICAL | 2070 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| isopropyl alcohol | ISOPROPYL ALCOHOL | ND2M416302 | OIL / TOPICAL | 72 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| isopropyl alcohol | ISOPROPYL ALCOHOL | ND2M416302 | SWAB / TOPICAL | 43.9 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| isopropyl alcohol | ISOPROPYL ALCOHOL | ND2M416302 | OIL / AURICULAR (OTIC) | 6 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| isopropyl alcohol | ISOPROPYL ALCOHOL | ND2M416302 | GEL / TOPICAL | 75 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| glycerin | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.